2.33
-0.07(-2.92%)
Currency In USD
| Previous Close | 2.4 |
| Open | 2.39 |
| Day High | 2.39 |
| Day Low | 2.32 |
| 52-Week High | 303.25 |
| 52-Week Low | 2.23 |
| Volume | 144,505 |
| Average Volume | 2.72M |
| Market Cap | 5.56M |
| PE | 0.01 |
| EPS | 264.12 |
| Moving Average 50 Days | 3.36 |
| Moving Average 200 Days | 58.75 |
| Change | -0.07 |
If you invested $1000 in ReShape Lifesciences Inc. (RSLS) since IPO date, it would be worth $0 as of July 30, 2025 at a share price of $2.33. Whereas If you bought $1000 worth of ReShape Lifesciences Inc. (RSLS) shares 5 years ago, it would be worth $0.02 as of July 30, 2025 at a share price of $2.33.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
ReShape Lifesciences® Announces Partial Adjournment of Special Meeting of Stockholders
GlobeNewswire Inc.
Jul 24, 2025 8:39 PM GMT
Partial Adjournment for Proposal 2, Asset Sale Proposal, and Proposal 3, Charter Amendment Proposal; All Other Proposals Required for Merger Were Approved Stockholders are encouraged to vote FOR Proposals 2 and 3 by Calling 1-877-750-8310 (from the U
ReShape Lifesciences® to Host Inaugural Lap-Band® Surgeon Summit
GlobeNewswire Inc.
Jul 22, 2025 12:31 PM GMT
Company to Host Pre-Eminent Lap-Band® Surgeon Advocates For a Three-Day Seminar, August 1-3, 2025IRVINE, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solu
ReShape Lifesciences® to Host Special Meeting of Stockholders on July 24, 2025
GlobeNewswire Inc.
Jul 21, 2025 6:10 PM GMT
Board of Directors Unanimously Recommend Approving Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys Shareholders are encouraged to vote FOR Proposals 1, 2, and 3 by Calling 1-877-750-8310 IRVINE, Calif., July